Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Applications
Isotype
Hersteller

Inhibitors & Compound Libraries

609594 Artikel

pro Seite

Seite:
  1. 93
  2. 94
  3. 95
  4. 96
  5. 97
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Org41841 Inhibitors Other Org-41841 is an agonist for the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) and partial agonist for TSHR. DCC-DC59012-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Org41841 Inhibitors Other Org-41841 is an agonist for the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) and partial agonist for TSHR. DCC-DC59012-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
Org41841 Inhibitors Other Org-41841 is an agonist for the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) and partial agonist for TSHR. DCC-DC59012-1g

DCChemicals 		1 g Anmelden
Vergleichen
SAR-­439859 Inhibitors Other SAR439859 is an orally available, nonsteroidal selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, SERD SAR439859 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells DCC-DC60004-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
SAR-­439859 Inhibitors Other SAR439859 is an orally available, nonsteroidal selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, SERD SAR439859 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells DCC-DC60004-1g

DCChemicals 		1 g Anmelden
Vergleichen
MK2-­IN-­3 Inhibitors Other MK2 Inhibitor III is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis. DCC-DC60011-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
MK2-­IN-­3 Inhibitors Other MK2 Inhibitor III is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis. DCC-DC60011-1g

DCChemicals 		1 g Anmelden
Vergleichen
hGPR91 antagonist 3 Inhibitors Other DCC-DC49871-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Mobocertinib (succinate) Inhibitors Other other DCC-DC60017-500mg

DCChemicals 		500 mg Anmelden
Vergleichen
(±)-­BAY-­1251152 Inhibitors Other AY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor. BAY1251152 binds to and blocks the phosphorylation and kinase activity of CDK9, thereby preventing PTEFb-mediated activation of RNA Pol II and leading to the inhibition of gene transcription of various anti-apoptotic proteins. This may cause cell cycle arrest and induce apoptosis, which may lead to a reduction in tumor cell proliferation. DCC-DC60039-50mg

DCChemicals 		50 mg Anmelden
Vergleichen
DSPE-­mPEG2000((sodium salt)) Inhibitors Other FC DCC-DC58047-1g

DCChemicals 		1 g Anmelden
Vergleichen
CPI-­0610 Inhibitors Other with potential antineoplastic activity. Upon administration, CPI-0610 is a small molecule inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, the BET inhibitor CPI-0610 binds to the acetylated lysine recognition motifs on the bromodomain of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histone peptides. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of tumor cell gro DCC-DC60048-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
CPI-­0610 Inhibitors Other with potential antineoplastic activity. Upon administration, CPI-0610 is a small molecule inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, the BET inhibitor CPI-0610 binds to the acetylated lysine recognition motifs on the bromodomain of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histone peptides. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of tumor cell gro DCC-DC60048-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
CPI-­0610 Inhibitors Other with potential antineoplastic activity. Upon administration, CPI-0610 is a small molecule inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, the BET inhibitor CPI-0610 binds to the acetylated lysine recognition motifs on the bromodomain of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histone peptides. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of tumor cell gro DCC-DC60048-1g

DCChemicals 		1 g Anmelden
Vergleichen
Avatrombopag Inhibitors Other ELISA, other DCC-DC57020-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Avatrombopag Inhibitors Other ELISA, other DCC-DC57020-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
Avatrombopag Inhibitors Other ELISA, other DCC-DC57020-1g

DCChemicals 		1 g Anmelden
Vergleichen
NB-­598 Inhibitors Other other DCC-DC60055-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
NB-­598 Inhibitors Other other DCC-DC60055-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
NB-­598 Inhibitors Other other DCC-DC60055-1g

DCChemicals 		1 g Anmelden
Vergleichen
PD-­123319 free base Inhibitors Other IC, other DCC-DC60068-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
PD-­123319 free base Inhibitors Other IC, other DCC-DC60068-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
PD-­123319 free base Inhibitors Other IC, other DCC-DC60068-1g

DCChemicals 		1 g Anmelden
Vergleichen
Sulfaproxyline Inhibitors Other Sulfaproxyline is antibiotics. DCC-DC60069-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Sulfaproxyline Inhibitors Other Sulfaproxyline is antibiotics. DCC-DC60069-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
Name Preis
Org41841 Anmelden Org41841
Typ Inhibitors
Clone
Specific against Other
Appl. Org-41841 is an agonist for the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) and partial agonist for TSHR.
Host
ArtNr.
Menge 100 mg
Lieferbar
Org41841 Anmelden Org41841
Typ Inhibitors
Clone
Specific against Other
Appl. Org-41841 is an agonist for the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) and partial agonist for TSHR.
Host
ArtNr.
Menge 250 mg
Lieferbar
Org41841 Anmelden Org41841
Typ Inhibitors
Clone
Specific against Other
Appl. Org-41841 is an agonist for the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) and partial agonist for TSHR.
Host
ArtNr.
Menge 1 g
Lieferbar
SAR-­439859 Anmelden SAR-439859
Typ Inhibitors
Clone
Specific against Other
Appl. SAR439859 is an orally available, nonsteroidal selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, SERD SAR439859 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells
Host
ArtNr.
Menge 100 mg
Lieferbar
SAR-­439859 Anmelden SAR-439859
Typ Inhibitors
Clone
Specific against Other
Appl. SAR439859 is an orally available, nonsteroidal selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, SERD SAR439859 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells
Host
ArtNr.
Menge 1 g
Lieferbar
MK2-­IN-­3 Anmelden MK2-IN-3
Typ Inhibitors
Clone
Specific against Other
Appl. MK2 Inhibitor III is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis.
Host
ArtNr.
Menge 100 mg
Lieferbar
MK2-­IN-­3 Anmelden MK2-IN-3
Typ Inhibitors
Clone
Specific against Other
Appl. MK2 Inhibitor III is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis.
Host
ArtNr.
Menge 1 g
Lieferbar
hGPR91 antagonist 3 Anmelden hGPR91 antagonist 3
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Mobocertinib (succinate) Anmelden Mobocertinib (succinate)
Typ Inhibitors
Clone
Specific against Other
Appl. other
Host
ArtNr.
Menge 500 mg
Lieferbar
(±)-­BAY-­1251152 Anmelden (±)-BAY-1251152
Typ Inhibitors
Clone
Specific against Other
Appl. AY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor. BAY1251152 binds to and blocks the phosphorylation and kinase activity of CDK9, thereby preventing PTEFb-mediated activation of RNA Pol II and leading to the inhibition of gene transcription of various anti-apoptotic proteins. This may cause cell cycle arrest and induce apoptosis, which may lead to a reduction in tumor cell proliferation.
Host
ArtNr.
Menge 50 mg
Lieferbar
DSPE-­mPEG2000((sodium salt)) Anmelden DSPE-mPEG2000((sodium salt))
Typ Inhibitors
Clone
Specific against Other
Appl. FC
Host
ArtNr.
Menge 1 g
Lieferbar
CPI-­0610 Anmelden CPI-0610
Typ Inhibitors
Clone
Specific against Other
Appl. with potential antineoplastic activity. Upon administration, CPI-0610 is a small molecule inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, the BET inhibitor CPI-0610 binds to the acetylated lysine recognition motifs on the bromodomain of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histone peptides. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of tumor cell gro
Host
ArtNr.
Menge 100 mg
Lieferbar
CPI-­0610 Anmelden CPI-0610
Typ Inhibitors
Clone
Specific against Other
Appl. with potential antineoplastic activity. Upon administration, CPI-0610 is a small molecule inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, the BET inhibitor CPI-0610 binds to the acetylated lysine recognition motifs on the bromodomain of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histone peptides. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of tumor cell gro
Host
ArtNr.
Menge 250 mg
Lieferbar
CPI-­0610 Anmelden CPI-0610
Typ Inhibitors
Clone
Specific against Other
Appl. with potential antineoplastic activity. Upon administration, CPI-0610 is a small molecule inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, the BET inhibitor CPI-0610 binds to the acetylated lysine recognition motifs on the bromodomain of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histone peptides. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of tumor cell gro
Host
ArtNr.
Menge 1 g
Lieferbar
Avatrombopag Anmelden Avatrombopag
Typ Inhibitors
Clone
Specific against Other
Appl. ELISA, other
Host
ArtNr.
Menge 100 mg
Lieferbar
Avatrombopag Anmelden Avatrombopag
Typ Inhibitors
Clone
Specific against Other
Appl. ELISA, other
Host
ArtNr.
Menge 250 mg
Lieferbar
Avatrombopag Anmelden Avatrombopag
Typ Inhibitors
Clone
Specific against Other
Appl. ELISA, other
Host
ArtNr.
Menge 1 g
Lieferbar
NB-­598 Anmelden NB-598
Typ Inhibitors
Clone
Specific against Other
Appl. other
Host
ArtNr.
Menge 100 mg
Lieferbar
NB-­598 Anmelden NB-598
Typ Inhibitors
Clone
Specific against Other
Appl. other
Host
ArtNr.
Menge 250 mg
Lieferbar
NB-­598 Anmelden NB-598
Typ Inhibitors
Clone
Specific against Other
Appl. other
Host
ArtNr.
Menge 1 g
Lieferbar
PD-­123319 free base Anmelden PD-123319 free base
Typ Inhibitors
Clone
Specific against Other
Appl. IC, other
Host
ArtNr.
Menge 100 mg
Lieferbar
PD-­123319 free base Anmelden PD-123319 free base
Typ Inhibitors
Clone
Specific against Other
Appl. IC, other
Host
ArtNr.
Menge 250 mg
Lieferbar
PD-­123319 free base Anmelden PD-123319 free base
Typ Inhibitors
Clone
Specific against Other
Appl. IC, other
Host
ArtNr.
Menge 1 g
Lieferbar
Sulfaproxyline Anmelden Sulfaproxyline
Typ Inhibitors
Clone
Specific against Other
Appl. Sulfaproxyline is antibiotics.
Host
ArtNr.
Menge 100 mg
Lieferbar
Sulfaproxyline Anmelden Sulfaproxyline
Typ Inhibitors
Clone
Specific against Other
Appl. Sulfaproxyline is antibiotics.
Host
ArtNr.
Menge 250 mg
Lieferbar

609594 Artikel

pro Seite

Seite:
  1. 93
  2. 94
  3. 95
  4. 96
  5. 97
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top